Category Archives: News

SOM Biotech Announces Initiation of Phase 2a Clinical Trial of SOM3355 in Huntington’s Disease Patients

BARCELONA, Spain and CAMBRIDGE, Massachusetts, July 17, 2018 — SOM Biotech, a clinical-stage biopharmaceutical company that discovers and develops drugs for orphan indications in the Central Nervous System, has announced today the successful initiation of Phase 2a clinical trial of its repurposed compound SOM3355 for the treatment of the chorea movements associated to Huntington’s disease. The Principal Investigator of the study is …

SOM Biotech presents to the BIO.NRW Investors Circle

This year, SOM Biotech was invited to present to the Investors Circle of the Business Angel Network of BIO.NRW on the 9th of July in Dusseldorf, Germany. SOM Biotech CEO Dr. Raúl Insa presented the company, highlighting its proven business model to the attending investors. The presentation platform is held three to four times a year in a strictly confidential …

SOM Biotech receives approval to start Huntington’s disease trial

SOM Biotech has received on 18th June 2018 the approval of the Clinical Trial Application (CTA), the European IND equivalent, from the Spanish Drug Agency (AEMPS) to conduct its Phase IIa, double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of SOM3355 in patients with choreic movements associated with Huntington’s disease. The study will be conducted in four major hospitals in …

SOM Biotech at Trifermed Awards 2018

The third edition of Trifermed Awards for Social Impact in Healthcare was held on 14th June 2018 at the CaixaForum in Barcelona, Spain.  The Trifermed Awards is a ceremony that recognizes motivated individuals and organizations that aim to improve the quality of healthcare in the society, with the common goal of developing a better world. According to Prof. Dr. Sergi …

1st National Congress on Muscular Dystrophy of Duchenne & Becker 2018

Parent Project España organized the 1st Congreso Nacional Duchenne which was held last 25th-27th May 2018 in Madrid. It aimed to help families and those affected gain access to the exchange of information and experiences in order to encourage mutual support and learn about the different aspects of Muscular Dystrophy of Duchenne and Becker. The congress mainly analyzed the …

SOM Biotech at Outsourcing in Clinical Trials Europe 2018

The 8th Annual Outsourcing in Clinical Trials Europe 2018 was held last 15th-16th May 2018 in Barcelona, Spain. It is the leading clinical trial outsourcing conference in Europe which aims to promote better collaboration between trial sponsors and solution providers, and provide attendees with practical take-aways that can be applied to their own operations. SOM Biotech Clinical Operations …

SOM Biotech at Genesis Drug Discovery 2018

The 2nd Annual Genesis Drug Discovery Conference was held last 10th-11th May 2018 in Barcelona, Spain. SOM Biotech CEO, Dr. Raúl Insa, gave an interesting talk on the “Systematic Drug Repurposing Discovery” wherein he discussed about drug repurposing and its advantages, and SOM Biotech’s technology, programs and business model. Dr. Raúl Insa during his session @ Genesis Drug Discovery …

Genesis Drug Discovery: Transforming the Future of Drug Discovery

The 2nd Annual Genesis Drug Discovery: “Transforming the Future of Drug Discovery” brings the most innovative event that aims to provide an open and stimulating scientific and cultural exchange that will give all the participants the opportunity to share their experiences, foster collaborations across industry and academia and evaluate emerging technologies across the globe. It will …

Sant Jordi Festival 2018

Each year, La Diada de Sant Jordi (St. George’s Day) is celebrated on the 23rd of April. Being Catalunya’s patron saint, Sant Jordi and his tale is well-known throughout the region. From his legend, the tradition of men giving roses to women was born. Book-giving during Sant Jordi became customary as well because World Book Day is …